School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR 999077, China.
Advanced Biomedical Instrumentation Centre, Hong Kong Science Park, Shatin, New Territories, Hong Kong SAR 999077, China.
Cells. 2022 Jan 4;11(1):159. doi: 10.3390/cells11010159.
A wide variety of nanomaterials have emerged in recent years with advantageous properties for a plethora of therapeutic and diagnostic applications. Such applications include drug delivery, imaging, anti-cancer therapy and radiotherapy. There is a critical need for further components which can facilitate therapeutic targeting, augment their physicochemical properties, or broaden their theranostic applications. Aptamers are single-stranded nucleic acids which have been selected or evolved to bind specifically to molecules, surfaces, or cells. Aptamers can also act as direct biologic therapeutics, or in imaging and diagnostics. There is a rich field of discovery at the interdisciplinary interface between nanomaterials and aptamer science that has significant potential across biomedicine. Herein, we review recent progress in aptamer-enabled materials and discuss pending challenges for their future biomedical application.
近年来,出现了各种各样的纳米材料,它们具有许多治疗和诊断应用的优势特性。此类应用包括药物输送、成像、抗癌治疗和放射治疗。人们迫切需要进一步的组件,这些组件可以促进治疗靶向、增强其物理化学性质或拓宽其治疗应用。适体是经过选择或进化的单链核酸,可特异性结合分子、表面或细胞。适体也可以作为直接的生物治疗药物,或用于成像和诊断。纳米材料和适体科学的交叉界面上有一个丰富的发现领域,在整个生物医学领域都有很大的潜力。在此,我们回顾了适体功能材料的最新进展,并讨论了其未来生物医学应用中存在的挑战。